Buchumschlag

Oral Immunotherapy Induces Shift in lncRNA Expression Modulating Allergen‐Specific Immune Responses

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Olivia Liong, Kati Palosuo, Victoria Hinkkanen, Vittorio Fortino, Mika J. Mäkelä, Piia Karisola
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Allergy
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Casein sIgE as the most accurate predictor for heated milk tolerance in Finnish children
von: Otso Nieminen, et al.
Veröffentlicht: (2025)

Allergen‐Specific Immunotherapy and Trained Immunity
von: Leticia Martín‐Cruz, et al.
Veröffentlicht: (2024)

Algorithms in Allergy: General Allergen Molecule‐Based Algorithm for Allergen‐Specific Immunotherapy
von: Huey‐Jy Huang, et al.
Veröffentlicht: (2026)

Allergen‐Specific Immunotherapy: The Need for Content Transparency
von: Melvin Lee Qiyu, et al.
Veröffentlicht: (2025)

Corrigendum to “Immune Regulation by Intralymphatic Immunotherapy With Modular Allergen Translocation MAT Vaccine”
Veröffentlicht: (2025)

Algorithms of Patient Selection for Allergen Immunotherapy
von: U. Petra Zieglmayer, et al.
Veröffentlicht: (2026)

Allergen‐Specific IgE is a Stronger Predictor of Remission Following Peanut Oral Immunotherapy Than Age in Children Aged 1–10 Years
von: Sarah E. Ashley, et al.
Veröffentlicht: (2024)

Correspondence: First Peanut ( Arachis hypogaea ) Allergen Oral Immunotherapy Product Out of Sale—A Major Drawback for Food Allergy Immunotherapy?
von: S. Arasi, et al.
Veröffentlicht: (2026)

Integrated Methylome–Transcriptome Analysis Reveals Epigenomic Remodeling and Rho GTPase –Linked Immune–Epithelial Crosstalk in Atopic Dermatitis
von: Tiina Skoog, et al.
Veröffentlicht: (2026)

Intralymphatic Administration of Naked mRNA Induces Allergen‐Specific IgG , Promotes Th1 Responses and Reduces Anaphylactic Potential
von: Marta Paolucci, et al.
Veröffentlicht: (2025)

Allergen Immunotherapy for the Prevention and Treatment of Asthma
von: Thierry Batard, et al.
Veröffentlicht: (2024)

Recombinant Allergy Vaccine‐Induced Transmission of Maternal Allergen‐Specific Neutralizing IgG
von: George B. Pasikhov, et al.
Veröffentlicht: (2025)

The Minimal Clinically Important Difference in Allergen Immunotherapy: An Evidence‐Based Approach
von: Oliver Pfaar, et al.
Veröffentlicht: (2025)

Cost‐Effectiveness of Allergen Immunotherapy for Allergic Rhinitis: A Systematic Review
von: Joshua Jacob, et al.
Veröffentlicht: (2026)

Biphasic Effects on Allergen‐Specific Type 2 Memory B Cells Over 18 Months Sublingual Immunotherapy for House Dust Mite Allergy
von: Lin Hsin, et al.
Veröffentlicht: (2026)

Real‐World Effectiveness for Sublingual Allergen Immunotherapy Among School‐Aged Children and Adolescents
von: Yusuke Okubo, et al.
Veröffentlicht: (2025)

Long‐Term, Real‐World Effectiveness of Allergen Immunotherapy in Children and Adolescents With Allergic Rhinitis and Asthma
von: Christian Woehlk, et al.
Veröffentlicht: (2025)

Revealing the Diverse Allergenic Protein Repertoire of Six Widely Consumed Crab Species: A Species‐Specific Allergen in King Crab
von: Shanshan Li, et al.
Veröffentlicht: (2025)

Use of Allergen Immunotherapy in China: Current Status and Research Progress
von: Song Li, et al.
Veröffentlicht: (2025)

The Drop of Allergen Immunotherapy for Respiratory Allergy in Italy: An Assessment of Sales
von: Mattia Giovannini, et al.
Veröffentlicht: (2025)

Characterization of Human Group 9 Innate Lymphoid Cells in Response to Allergen Immunotherapy in Patients With Allergic Rhinitis
von: Ya‐Qi Peng, et al.
Veröffentlicht: (2025)

Correspondence to “Characterization of Human Group 9 Innate Lymphoid Cells in Response to Allergen Immunotherapy in Patients With Allergic Rhinitis”
von: Jiayuan Huang, et al.
Veröffentlicht: (2026)

Circulating Type 2 Memory B Cell Frequency Is a Biomarker for Allergen Immunotherapy Efficacy in Patients With Allergic Rhinitis
von: Yue Ma, et al.
Veröffentlicht: (2026)

Early Changes in House Dust Mite Component Specific Immunoglobulin Levels Predict the One‐Year Efficacy of Allergen Immunotherapy in Patients With Allergic Rhinitis
von: Shuying Li, et al.
Veröffentlicht: (2025)

Long‐Term Effect of Allergen Immunotherapy in Responder Local Allergic Rhinitis Patients: Symptom Control, and Prevention of Asthma and Allergic Sensitizations
von: Almudena Testera‐Montes, et al.
Veröffentlicht: (2025)

Allergen‐Specific B Cell Responses Following Desensitisation and Natural Tolerance to Cow's Milk Allergy
von: Mohamed H. Shamji, et al.
Veröffentlicht: (2024)

Adherence to Grass Pollen Allergen Immunotherapy and Allergy Medication Use in Patients With Allergic Rhinitis
von: Morten Borg, et al.
Veröffentlicht: (2025)

Anaphylaxis Induced by Goat's and Sheep's Milk: An Allergen That We Should Keep Under Surveillance
von: Guillaume Pouessel, et al.
Veröffentlicht: (2025)

Narrowband Ultraviolet B Induces Peripheral Regulatory T Cells to Exert Antigen‐Specific Immune Suppression
von: Chun‐Hao Lu, et al.
Veröffentlicht: (2025)

A Systematic Review and Meta‐Analysis on the Induction of Confirmed Eosinophilic Esophagitis as a Side Effect of Allergen Immunotherapy: An EAACI Task Force Report
von: Carlo Maria Rossi, et al.
Veröffentlicht: (2025)

Subcutaneous Allergen‐Specific Immunotherapy for Allergic Rhinitis: Divergent IgA Responses in Nasal Mucosa and Blood With Validation of B Cell Class‐Switching in Lymph Nodes and Blood
von: Maryam Jafari, et al.
Veröffentlicht: (2025)

Effects of Butyrylated High Amylose Maize Starch ( HAMSB ) as an Adjuvant for Oral Immunotherapy
von: Duan Ni, et al.
Veröffentlicht: (2025)

Oral Immunotherapy of Peanut Allergy: A Critical Role for Gut‐Associated Immunity
von: A. Kuehn, et al.
Veröffentlicht: (2025)

Peanut Component‐Specific IgE and IgG4 Are Modulated by Sublingual Immunotherapy and Are Associated With Remission in 1–4‐Year‐Old Children
von: Neel Singh, et al.
Veröffentlicht: (2025)

Nematode in Cockroaches: A Potential Allergen Source
von: Dongjun Kang, et al.
Veröffentlicht: (2026)

Codfish Oral Immunotherapy in Children Aged 2–10: Randomized Placebo‐Controlled Study
von: Agnes Sze‐yin Leung, et al.
Veröffentlicht: (2026)

Protective Role for Itaconate During Inhaled Allergen Challenge
von: Gesa J. Albers, et al.
Veröffentlicht: (2025)

Inflammatory Mediator Profiles in the Unchallenged Sinonasal Mucus of Allergic Rhinitis Patients Set to Begin Allergen Immunotherapy
von: Cameron P. Worden, et al.
Veröffentlicht: (2025)

Systematic Review and Meta‐Analysis of Oral Immunotherapy Effect on Food Allergy‐Related Quality of Life
von: Sophie A. Rosser, et al.
Veröffentlicht: (2025)

Evaluation of the Quality and Reliability of ChatGPT‐4's Responses on Allergen Immunotherapy Using Validated Instruments for Health Information Quality Assessment
von: Ivan Cherrez‐Ojeda, et al.
Veröffentlicht: (2025)